drugset / Trial / NCT02241941

Evaluation of Single-dose Pharmacokinetics of Intravenous Daptomycin in Patients With Thermal Injury

NCT02241941 ↗

Phase 4 Withdrawn University of Zurich
NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to determine single dose pharmacokinetics of daptomycin consecutively in 10 patients on three different time points after severe burn injury.

Timeline

Start
2014-09
Primary completion
2016-10
Completion
2016-10

Outcome

Outcome not reported

Stopped: “Assessment of daptomycin concentrations with microdialysis technically not feasible”

Drugs

EvaluationDrugModalityDoseRoute
Subject Daptomycin Other / unclassified — Intravenous

Indications

No indication recorded.